Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre is a £100M collaboration between Oxford University Hospitals NHS Trust and the University of Oxford to accelerate healthcare innovation. Renewed in 2013, with a 50% increase in funding, the BRC features major neuroscience research themes including cerebrovascular disease and dementia led by Peter Rothwell, and functional neuroscience and imaging led by Peter Brown.

The centre held its third research open day on 19 May. The event attracted over 600 people including patients, the general public, patient representatives and staff.

The neuroscience stands included displays of transcranial direct current stimulation and prism glasses being investigated as potential aids to stroke recovery. Interactive exhibits included methods used to measure pain sensitivity, a demonstration of behavioural tasks used to investigate motor learning, and the use of Doppler ultrasound to screen for carotid plaques.

One of the highlights of the day was an eloquent and moving speech by Jonathan Wyatt, a patient from a gene therapy trial conducted in our Department, explaining his motivation for taking part in research and the remarkable results of the pilot trial. You can read more about this in the choroideremia gene therapy press release.

The event received widespread coverage in the local press and on radio.

Visit the BRC website.

Similar stories

Seminar Summary: Unravelling the inflammatory neuropathies

Clinical Neurology Event Research

Dr Alexander Davies summarises a departmental seminar by Dr Simon Rinaldi

Wolfson Building housing stroke centre opens

Event Research

Research into strokes and vascular dementia took a major step forward on Thursday 5 March with the official opening of our Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) based at the new Wolfson Building.

Our researchers test ‘Viagra’ drug to prevent recurrent strokes

Research Stroke & Dementia

Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.

Masonic Charitable Foundation Fund Studentship at Centre for the Prevention of Stroke and Dementia

Stroke & Dementia Teaching

The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.

Thomas Willis Day 2019

Event

On 16 May we celebrated the work of our Department over the previous year, marking our successes in research, teaching and public engagement.

Risk of dementia after TIA or stroke

Stroke & Dementia

Risk of dementia after stroke is a major concern for patients and carers. Reliable data on risk of dementia, particularly after TIA or minor stroke, are scarce.